Visible-Light Spider Silk Bioink for Cell-Safe 3D Hydrogel Printing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional bio-inks, such as collagen and alginate, require ultraviolet (UV) light for effective crosslinking, which can damage cells and have limited penetration depth, making them unsuitable for sensitive biological applications.

Innovation Solution

A photocrosslinkable bioink composition using a recombinant spider silk protein, visible light-reactive polymers, and photoinitiators like tris(bipyridine)ruthenium(II) chloride with ammonium persulfate, eosin Y with triethanolamine, or riboflavin with ammonium persulfate, allowing crosslinking under visible light to form biocompatible hydrogels.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If UV light is used for crosslinking conventional bio-inks (collagen, alginate), then crosslinking effectiveness is improved, but cell viability deteriorates due to cytotoxicity and limited penetration depth

Engineering Contradiction:
Improvecrosslinking effectivenessVSAvoidcell viability
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the wavelength parameter of the curing light from UV range to visible light range (405-520 nm). This parameter change allows the use of photoinitiators that activate under visible light, thereby eliminating UV-induced cytotoxicity while maintaining effective crosslinking of the bioink composition containing spider silk protein and photopolymerizable monomers.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces visible light photoinitiators (such as tris(bipyridine)ruthenium(II) chloride, eosin Y, riboflavin, or lithium phenyl-2,4,6-trimethylbenzoylphosphinate) as intermediary substances that mediate the crosslinking process. These photoinitiators absorb visible light and generate reactive species that initiate polymerization without requiring direct UV exposure, thus protecting cells from UV damage while achieving effective crosslinking.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If UV light is used for crosslinking, then crosslinking effectiveness is improved, but light penetration depth deteriorates in biological tissues

Engineering Contradiction:
Improvecrosslinking effectivenessVSAvoidlight penetration depth
Core Design Contradiction:
ReliabilityVSLength of stationary object

Solution Approach 1:

The patent changes the light wavelength parameter from UV to visible range (405-520 nm). Visible light has longer wavelength and lower energy than UV light, enabling deeper penetration through biological tissues and hydrogel matrices while still providing sufficient energy to activate the photoinitiators for effective crosslinking.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If UV light is used for crosslinking, then crosslinking effectiveness is improved, but harmful factors generated deteriorate (reactive oxygen species damaging nucleic acids and proteins)

Engineering Contradiction:
Improvecrosslinking effectivenessVSAvoidreactive oxygen species
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

The patent employs visible light photoinitiators as intermediary substances that generate reactive species only upon absorption of visible light. These photoinitiators (such as tris(bipyridine)ruthenium(II) chloride, eosin Y, riboflavin, or lithium phenyl-2,4,6-trimethylbenzoylphosphinate) mediate the crosslinking process without generating the harmful reactive oxygen species that UV light produces, thereby eliminating damage to nucleic acids and proteins while maintaining effective crosslinking.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent converts the potential harm of requiring high-energy UV light for crosslinking into a benefit by using visible light photoinitiators. The visible light photoinitiators capture the energy from visible light (which is safer for cells) and convert it into the reactive species needed for crosslinking, thereby eliminating the harmful UV radiation while maintaining the necessary crosslinking effectiveness.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The bioink composition supports cell adhesion and proliferation with enhanced printability and structural fidelity, providing a safer and more compatible environment for cell-laden constructs.

Implementation Method 1

a polymer comprising pendant groups reactive under visible light-initiated radical polymerization; and a photoinitiator system configured to generate free radicals upon exposure to visible light

Methodology Applied
Scientific EffectPhotopolymerization: Photopolymerisation

Data Source

PatentUS20260071174A1Photocrosslinkable bioink composition for three-dimensional printing and method of fabricating biocompatible three-dimensional hydrogel construct
Publication Date: 2026.03.12 CITY UNIVERSITY OF HONG KONG
  • US20260071174A1 patent drawing
  • US20260071174A1 patent drawing
  • US20260071174A1 patent drawing

AI summary

A photocrosslinkable bioink composition for three-dimensional printing is provided. The photocrosslinkable bioink composition includes: an aqueous solution of a recombinant spider silk protein comprising the NT2RepCT-MaSp2 sequence; a polymer comprising pendant groups reactive under visible light-initiated radical polymerization; and a photoinitiator system configured to generate free radicals upon exposure to visible light. The polymer is selected from the group consisting of methacrylated gelatin, methacrylated hyaluronic acid, methacrylated chitosan, polyethylene glycol diacrylate, and combinations thereof. The photoinitiator system is selected from the group consisting of tris(bipyridine)ruthenium(II) chloride with ammonium persulfate, eosin Y with triethanolamine, riboflavin with ammonium persulfate, and lithium phenyl-2,4,6-trimethylbenzoylphosphinate. The photocrosslinkable bioink composition is curable under visible light to form a biocompatible hydrogel structure suitable for cell culture or implantation.